Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard C. Becker

Showing results (51-60 of 329) with videos related to

Pageof 33
Sort By:
Journal of Thrombosis and Thrombolysis|April 25, 2024
The foundation for investigating factor XI as a target for inhibition in human cardiovascular diseaseAhmed E Ali, Richard C Becker
Journal of Thrombosis and Thrombolysis|June 13, 2020
Point-of-care platelet function tests: relevance to arterial thrombosis and opportunities for improvementDiana A Gorog, Richard C Becker
Drugs|September 15, 2010
Thrombin receptor antagonists for the treatment of atherothrombosis: therapeutic potential of vorapaxar and E-5555Sergio Leonardi, Pierluigi Tricoci, Richard C Becker
Current Opinion in Molecular Therapeutics|April 14, 2006
Nucleic acid aptamers as adjuncts to vaccine developmentKristian C D Becker, Richard C Becker
Journal of Thrombosis and Thrombolysis|August 5, 2021
COVID-19 and biomarkers of thrombosis: focus on von Willebrand factor and extracellular vesiclesRichard C Becker, Travis Sexton, Susan Smyth, et al.
Current Cardiology Reports|May 1, 2010
Antithrombotic therapy in acute coronary syndrome: how far up the coagulation cascade will we go?Becky Woodruff, Bruce Sullenger, Richard C Becker
Thrombosis and Haemostasis|June 22, 2005
Nucleic acid aptamers in therapeutic anticoagulation. Technology, development and clinical applicationRichard C Becker, Christopher Rusconi, Bruce Sullenger
Advances in Cardiology|August 22, 2012
Protease-activated receptor-1 inhibitors: a novel class of antiplatelet agents for the treatment of patients with acute coronary syndromeSergio Leonardi, Pierluigi Tricoci, Richard C Becker
Nature Reviews. Cardiology|August 10, 2011
The pharmacogenetics of antiplatelet agents: towards personalized therapy?Tariq Ahmad, Deepak Voora, Richard C Becker
Thrombosis Research|May 28, 2020
The potential roles of Von Willebrand factor and neutrophil extracellular traps in the natural history of hypertrophic and hypertensive cardiomyopathyRichard C Becker, A Phillip Owens, Sakthivel Sadayappan
Pageof 33

Showing results (51-60 of 329) with videos related to

Sort By:
Pageof 33
Journal of Thrombosis and Thrombolysis|April 25, 2024
The foundation for investigating factor XI as a target for inhibition in human cardiovascular diseaseAhmed E Ali, Richard C Becker
Journal of Thrombosis and Thrombolysis|June 13, 2020
Point-of-care platelet function tests: relevance to arterial thrombosis and opportunities for improvementDiana A Gorog, Richard C Becker
Drugs|September 15, 2010
Thrombin receptor antagonists for the treatment of atherothrombosis: therapeutic potential of vorapaxar and E-5555Sergio Leonardi, Pierluigi Tricoci, Richard C Becker
Current Opinion in Molecular Therapeutics|April 14, 2006
Nucleic acid aptamers as adjuncts to vaccine developmentKristian C D Becker, Richard C Becker
Journal of Thrombosis and Thrombolysis|August 5, 2021
COVID-19 and biomarkers of thrombosis: focus on von Willebrand factor and extracellular vesiclesRichard C Becker, Travis Sexton, Susan Smyth, et al.
Current Cardiology Reports|May 1, 2010
Antithrombotic therapy in acute coronary syndrome: how far up the coagulation cascade will we go?Becky Woodruff, Bruce Sullenger, Richard C Becker
Thrombosis and Haemostasis|June 22, 2005
Nucleic acid aptamers in therapeutic anticoagulation. Technology, development and clinical applicationRichard C Becker, Christopher Rusconi, Bruce Sullenger
Advances in Cardiology|August 22, 2012
Protease-activated receptor-1 inhibitors: a novel class of antiplatelet agents for the treatment of patients with acute coronary syndromeSergio Leonardi, Pierluigi Tricoci, Richard C Becker
Nature Reviews. Cardiology|August 10, 2011
The pharmacogenetics of antiplatelet agents: towards personalized therapy?Tariq Ahmad, Deepak Voora, Richard C Becker
Thrombosis Research|May 28, 2020
The potential roles of Von Willebrand factor and neutrophil extracellular traps in the natural history of hypertrophic and hypertensive cardiomyopathyRichard C Becker, A Phillip Owens, Sakthivel Sadayappan
Pageof 33